Bain Capital Life Sciences Opportunities III LP 13D and 13G filings for Cara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 6:50 pm Sale | 2023-12-31 | 13G | Cara Therapeutics, Inc. CARA | Bain Capital Life Sciences Opportunities III LP | 0 0.000% | -224,669 (Position Closed) | Filing |
| 2022-11-18 4:16 pm Purchase | 2022-11-09 | 13G | Cara Therapeutics, Inc. CARA | Bain Capital Life Sciences Opportunities III LP | 224,669 5.000% | 224,669 (New Position) | Filing |